The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the analgesic effect of GW493838 in patients with
post-herpetic neuralgia or peripheral nerve injury caused by trauma or surgery.